The use of oligonucleotides as therapeutics requires the packaging into nanoparticles. Positively charged peptides are one type of molecules to generate such nano-formulations. To this point, the inner architecture of these nanoparticles and how it depends on the relative amounts of oligonucleotide and peptide could not be resolved.
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
.jpg.aspx?width=500&height=389&ext=.jpg&type=BlockColumn1Zoom1)
Surprisingly dominant cause underlying type I congenital defect of glycosylation
21 October 2021Alex Garanto, Melissa Bärenfänger, Mirian Janssen, and Dirk Lefeber published a new study, identifying a surprisingly dominant genetic cause underlying type I congenital defect of glycosylation with neuromusculoskeletal phenotypes.
read more
Sensitive blood-test as a patient-friendly alternative for bone marrow-based cancer monitoring
20 October 2021Hans Jacobs and Pieter Langerhorst, theme Cancer development and immune defense, and colleagues are one step closer to implementation of personalized diagnostics for bone marrow-based cancer monitoring.
read more
Register for peer coaching for RIMLS PhD candidates
20 October 2021As a PhD candidate, you are in the lead of your own learning process, but you don’t need to do this alone. Register for the peer-coaching group ‘Stay in the lead – Together’ before 11 November 2021.
read more.aspx?width=4000&height=2670&ext=.jpeg&type=BlockColumn1Zoom1)
Frans Russel appointed member Supervisory Committee of RIVM
20 October 2021Frans Russel, theme Renal disorders, has been appointed by The Minister of Health, Welfare and Sport (VWS).
read more
Turbo Grants for four medical-technical research projects
19 October 2021Four TURBO grants were recently awarded to new technical-medical research proposals. The grants are part of the TURBO program, a collaboration between the University of Twente (TechMed Centre) and the Radboudumc.
read more